MedPath

Ambulatory CPAP Titration in Moderate Obstructive Sleep Apnea

Not Applicable
Completed
Conditions
Sleep Apnea, Obstructive
Interventions
Device: PAP titration at home
Registration Number
NCT04128930
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Brief Summary

The aim of this trial is to compare two different ways of CPAP titration:

CAP titration with fixed pressure vs. auto-titrating CPAP.

Detailed Description

Continuous positive airway pressure (CPAP) for the treatment of moderate obstructive sleep apnea (OSA) is only reimbursed in Belgium after in-laboratory overnight titration. Nevertheless, in a recent clinical practice guideline of the AASM, it is recommended that PAP therapy can be initiated using either in-laboratory titration or auto-titrating CPAP (APAP) at home in OSA patients without significant comorbidities. Indeed, several studies evaluated the impact of titration with APAP at home in these patients and showed that the outcome is comparable with in-hospital titration. Up to now, evidence for home titration with fixed CPAP (and follow-up via telemonitoring) is very limited. The use of sleep laboratory space is costly and limits access for diagnostic studies. This study aims to evaluate whether CPAP titration at home with fixed CPAP produces outcomes equal to those following APAP titration.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • moderate OSA (obstructive AHI 15-30/u on initial PSG)
Exclusion Criteria
  • Presence of hypoventilation
  • Presence of central sleep apnea (central AHI ≥ 15)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
APAP titration at homePAP titration at homePatients will start CPAP treatment with an auto-adjusting CPAP device with pressure levels between 4 and 12 cmH2O. After 7 nights of titration, the optimal pressure will be determined by analyzing the median of the nightly pressure that included 95% of the periods (percentile 95). CPAP treatment will be continued with this fixed optimal pressure.
Fixed CPAP titration at homePAP titration at homePatients will start CPAP treatment with a pressure that is calculated by the following formula (predicted pressure = (0.13 x BMI) + (0.16x neck circumference in cm) + (0.04 x AHI)) with a maximal pressure of 10 cmH2O. After 3 nights and after 7 nights, CPAP data will be remotely evaluated and pressure will be adapted based on the following rules: * After 3 nights: median obstructive AHI\<5/h: decrease pressure with 2 cmH2O; median obstructive AHI\>5/h: increase with 2cmH2O * After 7 nights: median obstructive AHI\>5/h of 4 nights after last adaptation: increase with 2 cmH2O
Primary Outcome Measures
NameTimeMethod
CPAP adherence3 months

Usage of the device (mean number of hours/day)

Secondary Outcome Measures
NameTimeMethod
Proportion of good titration2 weeks

Number of patients with residual AHI \< 10 (objectivated with PSG)

Epworth Sleepiness Scale3 months

Daytime sleepiness (range: 0-24 - higher score means worse outcome)

Blood pressure3 months

Blood pressure measurement

Hospital contacts3 months

Number of contacts with the hospital

Mask leaks2 weeks

Objective leaks (L/min) during CPAP treatment

Effective pressure level2 weeks

Optimal pressure of CPAP therapy

Pittsburgh Sleep Quality Index (PSQI)3 months

Sleep quality (range: 0-21 - higher score means worse outcome)

Residual apnea/hypopnea index2 weeks

Residual respiratory events during treatment with optimal CPAP pressure during PSG

Residual device AHI3 months

Residual AHI as determined from device data

36-Item Short Form Health Survey3 months

Quality of life (range: 0-100 - higher score means better outcome)

Trial Locations

Locations (1)

UZ Leuven

🇧🇪

Leuven, Belgium

© Copyright 2025. All Rights Reserved by MedPath